However, the actual contribution of NRF2 to tumour development and therapeutic responses in colorectal cancer remains unclear, with conflicting data regarding NRF2 levels, the relevance of its localisation and correlation with prognosis [28,29,30,31,32,33,34]. This evidence concerns the gene NFE2L2 and neoplasm.